Skip to main content
. 2023 Nov 18;9(4):137–141. doi: 10.1016/j.afos.2023.10.001

Table 2.

BMD changes after treatment.

Patient number Lumbar BMD (g/cm2)
Femoral neck BMD (g/cm2)
Before administering romosozumab 6 months later 1 year later Before administering romosozumab 6 months later 1 year later
1 0.478 0.628 0.668 0.339 0.331 0.421
2 0.438 0.520 0.524 0.417 0.547 0.513
3 0.491 0.575 0.620 0.314 0.327 0.366
4 0.653 0.714 0.756 0.456 0.420 0.409
5 0.906 0.959 0.999 0.490 0.475 0.547
Mean ± SD 0.593 ± 0.193 0.679 ± 0.172 0.713 ± 0.180 0.403 ± 0.075 0.420 ± 0.095 0.451 ± 0.075
P-value 0.01* 0.00* 0.60 0.13

*P-value <0.05; statistically significant compared to before administering romosozumab.

SD, standard deviation; BMD, bone mineral density.